Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults

Title
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Authors
Keywords
Anti-F IgG, F or fusion protein, Microneutralization, Nanoparticle vaccine, Palivizumab-competitive antibody (PCA), Recombinant, Respiratory syncytial virus (RSV), Avidity
Journal
Immunity & Ageing
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-12
DOI
10.1186/s12979-017-0090-7

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now